Propofol

Quick links to important sections

Propofol

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Propofol

Quick Facts

Property Description
Active ingredient Propofol (2,6-diisopropylphenol)
Form White oil-in-water emulsion for injection
Pharmacological class Intravenous General Anesthetic
Common use Induction and maintenance of general anesthesia
Origin Synthetic (Phenol derivative)

What Type of Medicine is Propofol?

Propofol is a powerful, prescription-only medication classified as an intravenous general anesthetic and a short-acting hypnotic agent. It is the mainstay drug in modern medicine used to induce a state of temporary, controlled unconsciousness for various medical procedures. Propofol belongs to the class of non-barbiturate anesthetics, distinguishing it from older compounds in this therapeutic category. Propofol's distinctive profile makes it the clinically recognized standard for inducing general anesthesia across diverse patient groups.

Composition and Unique Form of Propofol

The active ingredient in this medication is Propofol itself, but it must be prepared in a unique way for intravenous administration. Propofol is supplied as a sterile white oil-in-water emulsion for injection. Chemically, it is defined as a phenol derivative, specifically 2,6-diisopropylphenol, which is a synthetic compound entirely created in the laboratory. This distinctive emulsion form, which resembles milk, is necessary because the active substance is highly lipophilic (fat-soluble) and does not mix easily with water. The emulsion formulation uses components like Soybean oil and Purified egg lecithin as the vehicle, ensuring the drug is effectively dispersed into the bloodstream.

What is the General Purpose of Propofol?

The general purpose of Propofol is to achieve or maintain a state of general anesthesia for patients undergoing surgical operations or procedures. This means the medicine is specifically designed to suppress awareness and sensation during necessary medical interventions. Its functional profile is based entirely on its ability to produce immediate, controlled, and reversible unconsciousness. Beyond surgery, Propofol is widely used to provide controlled, deeper sedation for critical care patients or during short, invasive diagnostic procedures requiring the suppression of consciousness and memory.

Regulatory References

  1. NIH Propofol Drug Record

What side effects are possible with Propofol?

Possible Side Effects and Safety Information

The safety profile of Propofol is formally classified by government regulatory agencies based on the frequency and type of documented adverse reactions. These effects are primarily categorized by the physiological system they involve, as documented in official prescribing information.

Frequency-Classified Adverse Reactions

Adverse reactions are formally grouped by incidence, helping to structure the overall safety understanding:

Classification Examples of Reactions
Very Common (ge 10%) Transient local pain at the injection site.
Common (1% to <10%) Hypotension (low blood pressure), Bradycardia (slow heart rate), Transient Apnoea (brief cessation of breathing during induction), Nausea, Vomiting.
Uncommon (0.1% to <1%) Thrombosis or phlebitis at the injection site.
Very Rare (<0.01%) Anaphylaxis, Pulmonary Oedema.

Serious Safety Considerations

The official labeling documents rare but clinically significant adverse reactions. The most notable serious concern associated with prolonged, high-dose infusions, such as in critical care settings, is Propofol Infusion Syndrome (PRIS). PRIS is a severe complication characterized by a cluster of metabolic and organ failures, including severe metabolic acidosis, rhabdomyolysis, and cardiac failure.

Population and Exposure Constraints

The label includes specific safety constraints related to patient groups and exposure duration. Propofol is contraindicated in patients with a known hypersensitivity to the drug or any component of the emulsion, such as egg or soy products. Furthermore, its use is restricted for ICU sedation in the paediatric population (children le 16 years old) due to the heightened risk of PRIS. Older adults may experience an increased risk of significant cardiorespiratory depression during administration.

Overdose and Emergency Response

Overdose and when to seek help

The Propofol overdose profile is officially defined by an intensification of its expected effects, resulting from an excessive dose or over-rapid administration. The primary manifestations listed in regulatory documents involve profound cardiorespiratory depression, specifically leading to severe arterial hypotension, apnea (cessation of breathing), airway obstruction, and oxyhemoglobin desaturation.

Official Overdose Presentations and Actions

Classification Manifestation/Required Action
Acute Manifestation Profound cardiorespiratory depression, leading to cardiac arrest and asystole.
Toxicity Syndrome Propofol Infusion Syndrome (PRIS), defined by severe metabolic acidosis, rhabdomyolysis, and renal/cardiac failure in cases of prolonged, high-dose exposure.
Help-Seeking Mandate Seek immediate medical attention for any suspected overdose or symptom of severe depression, as the condition is life-threatening.
Management Note No specific antidote or reversal agent is known; treatment relies on symptomatic and supportive treatment, including artificial ventilation and use of pressor agents to stabilize blood pressure.

Regulators note that geriatric patients and pediatric patients are specific populations with an increased risk of severe cardiorespiratory depression. Given the potential for life-threatening outcomes, continuous monitoring of cardiorespiratory status is mandated in such situations.

Therapeutic Uses of Propofol

What Propofol Treats: Main Uses and Benefits

Propofol is commonly used across clinical domains defined by the need for controlled suppression of awareness, sensation, and physical reaction. Its core therapeutic benefit is considered relevant for medically necessary interventions by providing professional, reversible unconsciousness and deep sedation.

Propofol is specifically indicated for multiple uses that fall within the spectrum of general anesthesia and sedation.

This medicine is commonly used to help with inducing and maintaining general anesthesia for surgical operations, providing deep and sustained sedation for patients in the Intensive Care Unit (ICU) who require mechanical ventilation, and facilitating procedural sedation during various diagnostic or therapeutic interventions. This range of uses supports patients during difficult episodes by easing distress associated with severe symptoms.

Quick Fact: Relief for Symptom Clusters

Therapeutic Focus Symptoms Addressed
Anesthesia Conscious perception, painful sensation
Critical Care Agitation, intolerance of life support
Procedures Awareness, memory formation

“This medicine assists with maintaining comfort for patients requiring prolonged critical care and supports patients during episodes of heightened discomfort associated with necessary surgical interventions.”

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Propofol

Official regulatory documents define strict population eligibility for Propofol, primarily based on patient age, allergies to the formulation's components, and clinical status.

Eligibility Scope Detail
Populations for whom use is contraindicated: Patients with known hypersensitivity to Propofol or any component of its emulsion vehicle, including eggs, egg products, soybeans, or soy products.
Age-related eligibility rules: Use is approved for Adults across all indications. Pediatric use is restricted: General Anesthesia Induction is not recommended below 3 years of age, and Maintenance is not recommended below 2 months of age.
Use Not Established/Not Recommended: Safety and effectiveness are not established for use in Pediatric ICU Sedation or Pediatric MAC Sedation. Propofol is not recommended for use in obstetrics (including Cesarean section deliveries), due to the potential for neonatal depression.
Eligibility-related restrictions: Elderly, debilitated, or severely ill (ASA-PS III/IV) patients require special caution; rapid bolus administration must not be used during MAC Sedation in these high-risk groups. Use requires caution in patients with hyperlipidemia or severe systemic infection (sepsis).
Pregnancy and lactation eligibility status: Pregnancy: Use is restricted to situations where the potential benefit justifies the risk, as the drug crosses the placenta. Lactation: Although Propofol is excreted in small amounts in breast milk, most official guidance suggests breastfeeding can resume once the mother is fully recovered from anesthesia.

Official documents strictly regulate patient access by establishing absolute contraindications based on formulation allergy and setting specific, non-negotiable age limits and procedural prohibitions for pediatric use.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The documented interaction patterns for Propofol involve pharmacodynamic reinforcement, specific pharmacokinetic effects on exposure, and administration restrictions, all based on official regulatory labeling.

Documented Interaction Patterns

Interaction Type Interacting Substance/Class Official Outcome
Pharmacodynamic Opioids, Sedatives, Analgesics Co-administration may increase anesthetic/sedative and cardiorespiratory effects.
Pharmacokinetic Valproate May lead to increased blood levels and Propofol exposure.
Excipient-Based Egg, Soy Products Contraindicated in patients with known allergy due to emulsion components.

Administration and Contextual Constraints

Regulatory documents stipulate that Propofol must not be mixed with other solutions for injection prior to administration due to physical incompatibility constraints. The addition of other medicinal products into the Propofol infusion line must occur close to the cannula site.

Concerning specific populations, the official labeling notes that in elderly or debilitated patients, the risk of cardiorespiratory effects, such as hypotension, is increased due to age-related alterations in drug clearance. Furthermore, Propofol is contraindicated for use in the sedation of pediatric patients (18 years or younger) in the Intensive Care Unit.

Mechanism of Action

Propofol primarily exerts its effects by engaging three mechanistic domains to induce rapid physiological changes.

Enhancing Brain's Inhibitory Signaling

Propofol's core mechanism is the positive allosteric modulation of the GABAA receptor, the principal target for inhibitory signaling in the CNS. By enhancing this inhibitory pathway, the agent significantly increases the influx of chloride ions ( Cl^-) into neurons, leading to widespread hyperpolarization and subsequent suppression of brain activity. This cascade directly produces the key physiological consequence of unconsciousness (hypnosis) and amnesia.


Dual Suppression of Excitatory Neurotransmission

The secondary action is by acting as a functional inhibitor on excitatory pathways. This involves directly blocking Voltage-Gated Sodium Channels necessary for signal propagation and non-competitive inhibition of NMDA Receptors. This dual approach contributes to a broad quieting of neuronal excitability and reinforces the resulting physiological effect of global CNS depression.


Modulation of Vascular and Autonomic Tone

Propofol also engages peripheral mechanistic domains, notably by causing a direct relaxation of vascular smooth muscle and suppressing the baroreceptor reflex. This physiological consequence is significant as the resultant widespread vasodilation and failure of the body's compensatory mechanisms lead to an inherent, dose-dependent reduction in arterial blood pressure.

Dosage and Administration Information

How Propofol is Used: Administration Guidelines

Propofol is administered exclusively by intravenous (IV) injection or continuous infusion within a controlled clinical environment. The medicine is supplied as a white 10 mg/ mL oil-in-water emulsion that requires strict aseptic technique for handling and administration. The prepared product must be used or discarded within 12 hours of opening or at the conclusion of the procedure, whichever occurs first.


Administration Protocols and Dosage Regimens

The dosage of Propofol is highly specific and must be titrated to the desired clinical effect (e.g., induction or maintenance of anesthesia, or sedation). Administration must be conducted by or under the direct supervision of personnel trained in the administration of general anesthesia.

Clinical Context Typical Adult Dose Pattern
Anesthesia Induction Initial dose of 2 to 2.5 mg/ kg administered by slow IV injection.
Anesthesia Maintenance Sustained via continuous variable-rate IV infusion, commonly 0.1 to 0.2 mg/ kg/ min.
ICU Sedation Continuous infusion rate, individualized and titrated, typically ranging 5 to 50 mcg/ kg/ min.

Population-Specific and Procedural Constraints

Instructions mandate precise dose adjustments for specific patient groups. Older adults or severely ill patients (ASA III or IV) require a dose reduction of approximately 80% of the usual initial adult dosage. Furthermore, rapid bolus administration is prohibited in these high-risk patients. For pediatric use, the medicine is generally not recommended for anesthesia induction in children under 3 years of age.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Propofol

Propofol was studied for its role in temporarily decreasing measured levels of conscious perception across several medical situations. The research base primarily consists of Randomized Controlled Trials (RCTs), systematic reviews, and large-scale observational studies that adhere to standards required for review by governmental health regulators. Research examined the physiological changes data show patterns related to in the short term.


Evidence for Use in General Anesthesia

Research examined Propofol for both the induction (starting) and maintenance (sustaining) of general anesthesia during surgical procedures. The core evidence comes from RCTs where Propofol was evaluated in adults undergoing diverse surgeries. Studies explored outcomes related to systemic or functional imbalance, such as the measured time intervals for achieving unconsciousness, and intervals for regaining responsiveness. Findings often describe measured time intervals relative to certain older intravenous agents. However, studies described immediate, transient changes in blood pressure and heart rate that research monitored during administration.

What remains uncertain: Limited information is available regarding functional or cognitive outcomes linked to a single anesthetic episode. Furthermore, the evidence base for certain high-risk patient subgroups, such as those with severe heart conditions, remains under evaluation through comparative studies.


Evidence for Use in Intensive Care Unit (ICU) Sedation

Comparative trials explored Propofol for providing sustained, deep sedation to critically ill patients who require mechanical ventilation in the ICU. Research examined outcomes related to systemic or functional imbalance, primarily focusing on maintaining the patient at a specific depth of sedation. Findings often data show patterns related to measured recovery intervals after the Propofol infusion was stopped, compared to those receiving benzodiazepine-based sedatives.

What remains uncertain: The data for prolonged continuous infusions (lasting multiple days) is limited. Limited information is available regarding the potential for drug-related metabolic issues when the medicine was observed in extended periods in critically ill patients.


Research Gaps and Unanswered Questions

The evidence base for Propofol's core uses in anesthesia and short-term sedation is well-documented. However, several research limitation frames are recognized by scientists. There is limited information for long-term outcomes following single or prolonged exposure, as most studies focus on immediate effects. Additionally, subgroup findings are uncertain for specific, complex patient groups with multiple pre-existing conditions, where evidence quality varies across studies.

Frequently Asked Questions (FAQ)

Common questions about Propofol (FAQ)

Q: Why is Propofol sometimes called 'milk of amnesia'?

A: Propofol is manufactured as a white, milky-looking emulsion, which accounts for the 'milk' part of the nickname. According to official product information, Propofol's clinical properties include the ability to produce amnesia (memory loss) during the medical procedure, which is an effect associated with the use of Propofol.

Q: Is it normal to feel a burning sensation when Propofol is first injected?

A: Pain or a burning sensation at the injection site is a commonly reported adverse reaction, according to regulatory documents. This is associated with the initial intravenous administration of the medicine.

Q: Why do doctors monitor breathing so closely when a patient receives Propofol?

A: Official warnings state that Propofol can cause dose-related respiratory depression (a decrease in breathing function). This critical risk is why regulatory guidance emphasizes the need for continuous monitoring by trained personnel.

Q: Is Propofol used for long-term sedation in the Intensive Care Unit (ICU)?

A: Propofol is officially approved for the sedation of intubated, mechanically ventilated patients in the ICU. The duration of use in this setting is typically limited to a period specified in the official label, such as up to five days, depending on the formulation.

Q: Is Propofol a common part of anesthesia for a colonoscopy or endoscopy?

A: Propofol is officially indicated for use as a sedative agent for monitored anesthesia care (MAC) sedation during diagnostic procedures. This category includes common procedures like colonoscopies and endoscopies.

Q: Are there risks associated with repeated use of Propofol?

A: Yes. Prolonged use or use at high doses is associated with the risk of developing a serious condition called Propofol Infusion Syndrome (PRIS). This risk highlights the necessity for close supervision during the drug's administration in medical settings.

Q: How is Propofol typically prepared before it is administered?

A: The Propofol emulsion is supplied as a sterile product and must be handled using strict aseptic technique (sterile procedures) to prevent contamination. Official instructions specify that the product must be used or discarded within a short time limit (often 12 hours) after opening.

Q: What is the typical monitoring process during Propofol administration?

A: Regulatory documents mandate that patients receive continuous monitoring throughout administration. This process involves tracking vital signs such as heart rate, blood pressure, and oxygen saturation, along with the patient's level of sedation.

Q: What are the different strengths or concentrations Propofol comes in?

A: Propofol is supplied mainly as a 10 mg/ mL injectable emulsion.

Q: What is Propofol most commonly used for in hospitals?

A: Propofol is officially approved for two main purposes: the induction and maintenance of general anesthesia during surgery, and for sedation in specific medical settings, such as during mechanical ventilation or diagnostic procedures.

Q: Is Propofol the same type of medicine as general anesthesia?

A: Propofol is classified as a short-acting intravenous general anesthetic agent. This means it is a type of medicine specifically designed to induce and maintain general anesthesia or deep sedation.

Q: Does Propofol make you forget the procedure?

A: Official information indicates that the medicine is associated with producing amnesia (memory loss) during the period of its effect. This property is common during its use for anesthesia.

Q: How quickly does Propofol start working after it's given?

A: Propofol is known for its speed. It is described in the official labeling as having a rapid onset of action, typically occurring within seconds of being injected into a vein.

Q: How long does the sleepiness from Propofol typically last?

A: The duration of effect is generally short because the medicine is rapidly broken down by the body. This quick metabolism allows for a rapid return to wakefulness after the administration is stopped.

Q: What are the most common side effects people notice when waking up?

A: Commonly reported side effects listed in regulatory documents include a drop in blood pressure (hypotension) and various respiratory events. These effects are closely monitored during and after the procedure.

Q: Can Propofol cause nausea or vomiting?

A: Nausea and vomiting are listed among the reported adverse reactions that may occur during the use of Propofol or during the recovery period.

Q: Is Propofol addictive or abused outside of medical settings?

A: Propofol has been noted in regulatory documents to have a potential for abuse. For this reason, it is subject to special security, handling, and record-keeping requirements in certain jurisdictions.

Q: Can Propofol be used for sedation in children?

A: Propofol is officially approved for sedation and general anesthesia in children, typically starting from 3 years of age and older, for specific procedures.

Q: Are there certain health conditions that mean I cannot have Propofol?

A: Regulatory documents list specific conditions that contraindicate the use of Propofol. These include a known hypersensitivity (allergy) to the drug itself or to any of the components used in its formulation.

Q: What common over-the-counter medicines interact with Propofol?

A: Official documents list that drugs causing CNS depression (a slowdown of brain activity), such as certain sedatives or pain relievers, may increase Propofol’s effects. This may affect the required dosage of Propofol.

Q: Does Propofol interact with alcohol or recreational substances?

A: Regulatory labels advise caution when Propofol is used with CNS depressants, which includes alcohol. The combined effect of these substances may be enhanced.

Q: Is it possible to be allergic to Propofol?

A: Yes. Hypersensitivity (allergic reaction) to the medicine or to any of its components is listed as a contraindication to its use.

Q: What kind of studies have been done on Propofol?

A: The approval of Propofol was based on data from clinical studies that evaluated its safety and effectiveness for general anesthesia, sedation, and use in specific patient populations.

Q: Do older adults or elderly patients react differently to Propofol?

A: Yes. Due to the potential for increased sensitivity to Propofol's effects on the heart and breathing, official prescribing information advises caution and potential dosage adjustment due to increased sensitivity.

Q: Can Propofol affect the heart or blood pressure?

A: Yes, regulatory warnings note that Propofol commonly causes a decrease in blood pressure (hypotension). It can also affect heart rate, and these effects make continuous monitoring of these vital signs critical during administration.

Q: Is Propofol considered a controlled substance?

A: In the United States, Propofol is not currently scheduled as a federally controlled substance by the DEA. However, it is subject to special handling, security, and record-keeping regulations.

Q: Can Propofol be used for pain relief?

A: Propofol is described in official clinical pharmacology sections as having no intrinsic analgesic properties (it does not relieve pain). If pain relief is required, Propofol is typically supplemented with a separate pain medication.

Q: What happens to Propofol in the body after the procedure?

A: Propofol is rapidly metabolized (broken down) by the body's tissues. This process allows for its quick elimination and contributes to the rapid recovery seen after administration is stopped.

Q: What groups of patients should avoid Propofol entirely?

A: Patients with a known hypersensitivity (allergy) to the medicine or to components of the formulation, such as soybean oil or egg products, are explicitly advised in official documents to avoid its use.

Q: Can Propofol cause vivid dreams or hallucinations upon waking?

A: Yes, dreaming, euphoria, or hallucinations during the emergence or recovery phase are listed as reported adverse events in the official label.

Q: Does having liver or kidney problems change how Propofol is used?

A: Caution is advised for patients with impaired liver or kidney function because these organs affect how the drug is metabolized. This may affect the drug's metabolism and require careful dose management.

Q: Is Propofol safe to use during pregnancy for procedures?

A: Regulatory information indicates that Propofol should be used during pregnancy only if clearly needed. The potential effects of the drug on the developing fetus are noted in the official prescribing documentation.

Q: What is the risk of waking up during a procedure while on Propofol?

A: The potential for anesthesia awareness (waking up) is a known risk during any procedure requiring anesthesia. For this reason, continuous monitoring and dose titration (adjustment) by trained professionals are employed to help maintain the appropriate level of sedation or anesthesia.

Q: What research is currently being done on Propofol?

A: Information regarding ongoing or recently completed clinical trials that examine the properties or new uses of Propofol is typically available through governmental research databases like Clinical Trials.gov.

Q: Does Propofol affect fertility?

A: Official nonclinical toxicology data from animal studies addresses the effects on fertility. these studies noted effects only at specific dosages that may be higher than those used clinically.

Q: Do patients typically remember anything after receiving Propofol for sedation?

A: Propofol is associated with producing amnesia (memory loss) during the procedure. The goal of using Propofol for sedation is to minimize or eliminate patient memory of the medical procedure.

Q: Can Propofol cause temporary confusion after the procedure?

A: Confusion or disorientation are listed as reported adverse reactions that may occur during the emergence phase as the patient recovers from the effects of the drug.

Q: Is Propofol used for minor surgeries or just major ones?

A: Propofol is approved for procedures requiring general anesthesia (which can include major surgeries) and for sedation for diagnostic procedures (which are often minor or non-surgical).

Q: What are the official warnings about Propofol related to breathing?

A: Official warnings emphasize the potential for dose-dependent respiratory depression (breathing slowdown) and the necessity of continuous patient monitoring and respiratory support availability.

Q: Is Propofol known to cause a drop in body temperature?

A: Hypothermia (a drop in body temperature) is listed as a reported adverse reaction in the official regulatory label.

Q: Can people with egg or soy allergies have Propofol?

A: Since the Propofol emulsion contains soybean oil, and because of its formulation, it may be contraindicated (advised against) for use in patients with known or suspected allergies to soy or eggs.

Q: Does Propofol interact with common blood thinners or anti-clotting medications?

A: The regulatory label lists various drug classes that may interact with Propofol, including those that affect coagulation (blood clotting). If these drugs are used, their interaction may require careful management of the Propofol dosage.

Q: How soon after receiving Propofol can a person typically drive or operate machinery?

A: Official patient information advises patients not to drive, operate machinery, or engage in risky activities for a specified recovery period, which is typically set at a minimum of 24 hours after receiving Propofol.

Q: Is there a reversal agent for Propofol if too much is given?

A: Official guidance for overdosage indicates there is no specific antidote or reversal agent for Propofol. Treatment consists of supportive care and symptomatic measures.

How should Propofol be stored and disposed of?

Storage and Disposal of Propofol

Propofol injection requires strict storage conditions to maintain its integrity as an emulsion. The medication must be stored at controlled room temperature, specifically between 20 C and 25 C. It is crucial that the product is protected from light and must not be frozen. Storage should be maintained in the original container until use.

Stability and Disposal

Due to the nature of the emulsion, any unused product or solution diluted for administration must be discarded within 12 hours of opening the container. For disposal, Propofol must be kept out of the sight and reach of children. All unused or expired product and waste materials must be discarded in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Propofol found in:

A-Z Index: